NCATS research addresses scientific and operational challenges that slow the development of the new interventions to improve human health. The Center aims to make translational science more efficient, less expensive and less risky.
-
Research
-
-
Funding & Notices
-
-
News & Media
-
About Translation
-
-
About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- NCATS Chemical Genomics Center (NCGC)
- NIH Common Fund Programs
- Pfizer's Centers for Therapeutic Innovation (CTI) for NIH Researchers
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Trans-NIH RNAi Facility (TNRF)
- Therapeutics for Rare and Neglected Diseases (TRND)
-